(Q35557679)

English

The essentiality of Bcl-2, PKC and proteasome–ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline

scientific article published on October 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline (English)

1 reference

Europe PubMed Central

8 August 2017

The essentiality of Bcl-2, PKC and proteasome–ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline (English)

1 reference

10.1016/S0006-2952(03)00535-5

https://api.crossref.org/works/10.1016/S0006-2952(03)00535-5

20 March 2024

ubiquitin-proteasome system

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0006-2952(03)00535-5

https://api.crossref.org/works/10.1016/S0006-2952(03)00535-5

20 March 2024

1 reference

10.1016/S0006-2952(03)00535-5

https://api.crossref.org/works/10.1016/S0006-2952(03)00535-5

20 March 2024

Moussa B. H. Youdim

1

object named as

Moussa B H Youdim

1 reference

Europe PubMed Central

8 August 2017

6

object named as

Makato Naoi

1 reference

Europe PubMed Central

8 August 2017

author name string

Tamar Amit

2

1 reference

Europe PubMed Central

8 August 2017

Merav Falach-Yogev

3

1 reference

Europe PubMed Central

8 August 2017

Orit Bar Am

4

1 reference

Europe PubMed Central

8 August 2017

Wakkako Maruyama

5

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

8 August 2017

15 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14555244

20 March 2024

number of pages

7

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:S0006295203005355?httpAccept=text/xml

1 reference

10.1016/S0006-2952(03)00535-5

https://api.crossref.org/works/10.1016/S0006-2952(03)00535-5

20 March 2024

https://api.elsevier.com/content/article/PII:S0006295203005355?httpAccept=text/plain

1 reference

10.1016/S0006-2952(03)00535-5

https://api.crossref.org/works/10.1016/S0006-2952(03)00535-5

20 March 2024

Biochemical Pharmacology

1 reference

Europe PubMed Central

8 August 2017

66

1 reference

Europe PubMed Central

8 August 2017

1635-1641

1 reference

Europe PubMed Central

8 August 2017

8

1 reference

Europe PubMed Central

8 August 2017

Using cDNA microarray to assess Parkinson's disease models and the effects of neuroprotective drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Tyramine antagonistic properties of AGN 1135, an irreversible inhibitor of monoamine oxidase type B.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Pharmacological properties of the anti-Parkinson drug rasagiline; modification of endogenous brain amines, reserpine reversal, serotonergic and dopaminergic behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Rat striatal monoamine oxidase-B inhibition by l-deprenyl and rasagiline: its relationship to 2-phenylethylamine-induced stereotypy and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-B.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

A controlled trial of rasagiline in early Parkinson disease: the TEMPO Study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Studies with rasagiline, a MAO-B inhibitor, in experimental focal ischemia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

The Pivotal Role of Iron in NF-kappaB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Effect of overexpression of BCL-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses, and the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Sparing by rasagiline (TVP-1012) of cholinergic functions and behavior in the postnatal anoxia rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Amyloid beta-protein and the genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Cleavage of amyloid beta peptide during constitutive processing of its precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

A portrait of Alzheimer secretases--new features and familiar faces

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

(-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900535-5

7 January 2021

Identifiers

10.1016/S0006-2952(03)00535-5

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35557679&oldid=2118888923"